Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid to Improve Same-day Discharge Rates After HoLEP
NCT05082142Phase 4Completed
- Sponsor
- Northwestern University
- Start
- Sep 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in benign prostatic hyperplasia (BPH), sponsored by Northwestern University. Started Sep 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT05082142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05082142.